Table 4.
Global-brain volumetric measurements in ALS patients with right or left limb-onset and respective normal controls by SIENAX.
| R_NC | R_limb-onset | P 1 | L_NC | L_limb-onset | P 2 | |
|---|---|---|---|---|---|---|
| BPF | 0.97 ± 0.007 | 0.96 ± 0.009 | 0.000 | 0.974 ± 0.006 | 0.971 ± 0.005 | 0.016 |
| NCV (mm3) | 576.90 ± 34.04 | 551.37 ± 28.93 | 0.008 | 588.46 ± 35.43 | 566.68 ± 25.80 | 0.053 |
| NGMV (mm3) | 726.61 ± 44.80 | 699.30 ± 39.59 | 0.042 | 746.02 ± 45.15 | 680.55 ± 167.20 | 0.113 |
| NWMV (mm3) | 703.38 ± 38.84 | 663.01 ± 28.44 | 0.001 | 694.24 ± 39.67 | 685.97 ± 27.15 | 0.402 |
P 1, P 2: P value in subgroup analysis between patients with right or left limb-onset and respective normal controls, by using analysis of covariance, adjusted for age.